Viewing data from:

OXAZEPAM

ANDA

OXAZEPAM | A218261 | LEADING PHARMA LLC

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 3 NDCs

Highest NADAC/Unit

$1.23

per ea

Lowest NADAC/Unit

$0.7131

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
69315091301OXAZEPAM 30 MG CAPSULE	$1.23	EA	Generic	—	2026-08-19
69315091201OXAZEPAM 15 MG CAPSULE	$0.9674	EA	Generic	—	2026-08-19
69315091101OXAZEPAM 10 MG CAPSULE	$0.7131	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 3 NDCs (3 FSS)

Lowest Price

$89.83

Highest Price

$164.04

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
69315-0911-01OXAZEPAM 10MG CAP	$89.83	FSS	Golden State Medical Supply, Inc.	06/14/2028
69315-0912-01OXAZEPAM 15MG CAP	$113.42	FSS	Golden State Medical Supply, Inc.	06/14/2028
69315-0913-01OXAZEPAM 30MG CAP	$164.04	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain5 active DMFs3 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

CAMBREX PROFARMACO MILANO SRLOXAZEPAM

DMF 44381982

FIS FABBRICA ITALIANA SINTETICI SPAOXAZEPAM

DMF 52081984

CENTAUR PHARMACEUTICALS PVT LTDOXAZEPAM USP

DMF 220602008

KALINTIS HEALTHCARE PVT LTDOXAZEPAM USP

DMF 367302022

RL FINE CHEM PVT LTDOXAZEPAM

DMF 404322024

SANDOZ LTD PHARMACEUTICAL DIV CHEMICAL DEVELOPMENTInactiveOXAZEPAM

DMF 49391983

WYETH-AYERST LABORATORIESInactiveOXAZEPAM

DMF 64451986

TEVA PHARMACEUTICAL INDUSTRIES LTDInactiveOXAZEPAM

DMF 181152005

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 10MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Mar 3, 2025

No patent or exclusivity listings for this strength.

#002 — 15MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Mar 3, 2025

#003 — 30MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Mar 3, 2025